{"prompt": "['Page 32 of 74', 'Protocol 036 (Nishijima, Kuppermann)', 'Estimated', 'BOLUS Total Dose', 'MAINTENANCE', 'BOLUS Total Dose', 'MAINTENANCE', 'Weight in', '(mg)', 'Total Dose (mg)', '(mg)', 'Total Dose (mg)', 'kg', '(calculated', 'TXA dose A: 15', 'TXA dose A: 15', 'TXA dose B: 30', 'TXA dose B: 30', 'weight)', 'mg/kg bolus over', 'mg/kg bolus over', 'mg/kg bolus over', 'mg/kg bolus over', '20 min then 2', '20 min then 2', '20 min then 4', '20 min then 4', 'mg/kg/hr over 8 hrs', 'mg/kg/hr over 8 hrs', 'mg/kg/hr over 8 hrs', 'mg/kg/hr over 8 hrs', 'Concentration: 20', 'Concentration: 20', 'Concentration: 40', 'Concentration: 40', 'mg/ml in a 100 ml', 'mg/ml in a 100 ml', 'mg/ml in a 100 ml', 'mg/ml in a 100 ml', 'vial', 'vial', 'vial', 'vial', '3-4.9', '60', '60', '120', '120', '5-7.4', '100', '100', '200', '200', '7.5-9.9', '140', '140', '280', '280', '10-12.4', '180', '180', '360', '360', '12.5-14.9', '220', '220', '420', '420', '15-19.9', '280', '280', '560', '560', '20-24.9', '360', '360', '720', '720', '25-29.9', '440', '440', '880', '880', '30-34.9', '520', '520', '1040', '1040', '35-39.9', '600', '600', '1200', '1200', '40-49.9', '720', '720', '1440', '1440', '50-59.9', '880', '880', '1760', '1760', '>60', '1000', '1000', '2000', '2000', 'Figure 7: Weight-Based Dosing of TXA Dose A and TXA Dose B', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']['Protocol 036 (Nishijima, Kuppermann)', 'Page 33 of 74', 'Child with Trauma Arrives in ED', 'Failed Screening', 'Screened by the ED Staff', 'Excluded', 'Eligibility Assessed by Member', 'of Investigative Team', 'Not Eligible', 'Enrolled with Informed', 'Consent or EFIC', 'Study Laboratory', 'RANDOMIZATION', 'Testing', 'TXA Dose A', 'TXA Dose B', 'Placebo', '15 mg/kg bolus &', '30 mg/kg bolus &', 'Normal Saline bolus &', '2 mg/kg/hr X 8 hours', '4 mg/kg/hr X 8 hours', '8 hr infusion', 'Outcomes Assessment', 'Figure 8: Study Flow Chart', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']['Page 34 of 74', 'Protocol 036 (Nishijima, Kuppermann)', '5', 'Data Analysis', '5.1 Outcomes', 'As this study is a pilot trial to collect preliminary data on safety and efficacy and to assess', 'feasibility of study procedures, the study is not powered for a particular endpoint. We will', 'collect the following outcomes: total blood products (ml/kg) transfused over the initial', '48 hours of care (children with torso injury), and intracranial hemorrhage progression in', 'first 24 hours (children with TBIs). We will also measure PedsQL TM (Pediatric Quality', 'of Life Inventory), Peds GOS-E, and digit span recall at 1 week, 1 month, 3 months, and', '6 months post-randomization (all subjects) Figure 9.', 'Randomized', 'Patient', 'Isolated', 'Torso +', 'Isolated', 'Torso', 'TBI', 'TBI', 'Torso Analysis: Peds QL (primary), Peds GOS-', 'TBI Analysis: PedsQL (primary), Peds', 'E, digit span test, biomarker tests, 48 hour', 'GOS-E, digit span test, biomarker tests, ICH', 'transfusion requirements, adverse events', 'progression, adverse events', 'Figure 9: Outcome Determination', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']\n\n###\n\n", "completion": "END"}